Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omecamtiv Mecarbil in Acute Heart Failure (ATOMIC-AHF)
NCT01300013Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of omecamtiv mecarbil in Acute Heart Failure (AHF), sponsored by Cytokinetics. Started Apr 2011; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT01300013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300013.